This guest blog post was provided by Premier Research.
According to the National Institutes of Health, 70% of medicines prescribed to children have been researched only in adults. However, pediatric regulatory changes over the past decade in the United States now mandate extensive research as a part of drug development.
Developing Pediatric Studies, outlines the special considerations needed to make your next pediatric clinical trial a success. Split into two sections, the first part concentrates on patient population considerations, while the second focuses on biostatistical and PK considerations for pediatric studies.
To download “Developing Pediatric Studies” whitepaper,
Or visit our resource center to discover how our experienced pediatric study teams can guide you through the process of pediatric clinical trials.